Vaccine For Child: The Subject Expert Committee (Sec) on Vaccination has recommended Bharat Biotech’s Covaxin for children aged 2 to 18 years.
COVAXIN For Child: After immunization of adults, now the way for immunization for children in the age group of 2 to 18 years in the country is also being cleared. The Subject Expert Committee (SEC) on Vaccination has approved Bharat Biotech’s Covaccine (Covaxin) The is recommended for children from 2 to 18 years. However, now it is awaiting the approval of the Drug Controller General of India (DCGI). After the approval of the expert panel, now the drug regulator will finally take a decision on this.Also Read – COVAXIN For Children: Children will get the vaccine, know when and how vaccination will start
Bharat Biotech for Children in the age group of 2 to 18 years by Subject Expert Committee COVID-19 Hours after the recommendation of the vaccine COVAXIN, Minister of State for Health Dr. Bharti Praveen Pawar clarified that the evaluation is still on. “There is some confusion and talks are on with the expert committee. Till now Drug Controller General of India (DCGI) has not approved it. He said that the work is going on now. The experts will decide after that the vaccine will come. The process is going on and we do not interfere in that. Also Read – Central Government Allows Export Of Russian Covid Vaccine Made In India Single Shot Sputnik Light
Work is going on now. I think there is some confusion coming up. DGCI’s approval has not been received yet. The experts will decide after that the vaccine will come. Process is underway and we do not interfere in it: Union Minister of State for Health Bharti Pravin Pawar on Children’s Corona Vaccine pic.twitter.com/slzzerU0UG
— ANI_HindiNews (@AHindinews) October 12, 2021
Also Read – Government Allows Export Of Russian COVID Vaccine Sputnik Lite Made In India, Only Single Dose…
It is known that the expert committee conducts scientific examination of the findings of the vaccine trial. It recommends it on the basis of all national and international standards. After this, if the drug regulator approves it, then the vaccine is approved under emergency use. If approval is received from the drug regulator, then soon the way for immunization of children in the country will open.
Earlier, Bharat Biotech said in a statement, ‘This is the first approval of Kovid-19 vaccines given for the age group of two to 18 years. Bharat Biotech thanks DCGI, Subject Expert Committee and CDSCO for their swift review. Now we are waiting for further regulatory approvals from CDSCO before launching the product. After this, Covaxin will be available in the market for children. Bharat Biotech said that the company has submitted data from clinical trials for the age group of two to 18 years to CDSCO. These figures were thoroughly reviewed by the CDSCO and the SEC and gave their positive suggestions.
Let us inform that at present, anti-corona vaccine is being administered to people above 18 years of age in the country. Covishield, Covaccine and Russian Sputnik V vaccines are currently being used in India. Some other vaccine companies are in different stages of testing. It is expected that soon some more vaccines will be ready to fight against Corona.